Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Jonathan W. Lewis

Jonathan W. Lewis

individual
Ecosystem influencer

About

Jonathan W. Lewis, Ph.D. is the Chief Business Officer at Calico, the Alphabet-founded biotech focused on aging and age-related diseases. According to Calico, he has led scientific collaborations, business partnerships, portfolio planning, and IP-related matters since joining in 2014, after prior business development roles at UCB Pharma, Roche, Genentech, and Credit Suisse First Boston. No reliable evidence surfaced that he deploys personal investment capital or operates an investment fund.

Areas of interest

longevitybiotechaging biologydrug discoveryscientific partnershipstranslational sciencemachine learning in drug discoveryoncologyneurodegenerationchronic inflammationmetabolic disorders